Bio-Pharmaceutical Logistics Market Report 2026

Bio-Pharmaceutical Logistics Market Overview

• Bio-Pharmaceutical Logistics market size has reached to $156.9 billion in 2025 • Expected to grow to $259.32 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: Rising Demand For Biologics Propels Growth In Bio-Pharmaceutical Logistics Market • Market Trend: IoT-Enabled Cold Chain Innovations Enhancing Pharmaceutical Distribution Efficiency • North America was the largest region in 2025.

What Is Covered Under Bio-Pharmaceutical Logistics Market?

Biopharmaceuticals refer to medical drugs produced using biotechnology. Biopharmaceutical logistics is the process of transportation, warehousing, packing, and shipping, as well as inventory management of biopharmaceuticals. It provides services for handling biopharmaceuticals such as plasma, and temperature-sensitive products, among others. The main types of bio-pharmaceutical logistics include cold chain logistics and non-cold chain logistics. Cold chain logistics is the technology and processes that allow for the safe transportation of temperature-sensitive products along the supply chain. The various services offered include transportation, warehousing and distribution and value-added services that are sold in specialty stores, hypermarkets and departmental stores for applications in ground shipping, sea shipping and air shipping and are used by various end-users such as pharmaceuticals, biopharmaceuticals, pharmacies, hospitals, clinics, supermarkets and others.

What Is The Bio-Pharmaceutical Logistics Market Growth Forecast?

The bio-pharmaceutical logistics market size is expected to see rapid growth in the next few years. It will grow to $259.32 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to expansion of personalized medicine distribution, rising investments in smart cold chain infrastructure, growing demand for cell and gene therapy logistics, increased adoption of digital tracking platforms, rising focus on sustainable pharma transportation. Major trends in the forecast period include increasing adoption of advanced cold chain solutions, rising use of real-time temperature monitoring, growing demand for specialized pharma logistics services, expansion of air freight for biologics, enhanced focus on regulatory compliance and traceability.

Global Bio-Pharmaceutical Logistics Market Segmentation

1) By Type: Cold Chain Logistics, Non-Cold Chain Logistics 2) By Service: Transportation, Warehousing And Distribution, Value Added Services 3) By Retail Format: Specialty Stores, Hyper Markets 4) By Application: Ground Shipping, Sea Shipping, Air Shipping 5) By End User: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Other End Users Subsegments: 1) By Cold Chain Logistics: Refrigerated Transport, Temperature-Controlled Warehousing, Packaging Solutions, Monitoring Systems 2) By Non-Cold Chain Logistics: Ambient Transport, Standard Warehousing, General Packaging Solutions

What Is The Driver Of The Bio-Pharmaceutical Logistics Market?

The increasing use of biologics is expected to propel the bio-pharmaceutical logistics market going forward. Biologics refers to powerful medication products that are produced from living organisms or contain components of living organisms. It is possible for biological drugs to interact with containers or packaging components due to their sensitivity, thus requiring cold or even cryogenic storage. Biopharmaceutical logistics provides services for handling biopharmaceuticals such as plasma, and temperature-sensitive products that enable access to life-saving healthcare products such as biologics, medicines, and vaccines.For instance, in January 2024, according to the IQV, a pharma clinical research company, a US-based company, global use of medicines grew by 14% over the past five years, and a further 12% increase is expected through 2028, bringing annual use to 3.8 trillion defined daily doses. Therefore, the increasing use of biologics is driving the bio-pharmaceutical logistics industry.

Key Players In The Global Bio-Pharmaceutical Logistics Market

Major companies operating in the bio-pharmaceutical logistics market are Kuehne + Nagel International AG, FedEx Corporation, SF Express Co. Ltd., Dalsey Hillblom and Lynn, Kerry Logistics Network Limited, AmerisourceBergen Corporation, United Parcel Service of America Inc., DB Schenker, Agility Public Warehousing Company K.S.C.P., C.H. Robinson Worldwide Inc., Ceva Logistics, Nippon Express, GEODIS S.A., Air Canada Cargo, World Courier Inc., QuickSTAT Global Life Science Logistics Inc., Marken, Biocair, Almac Group, PCI Pharma Services Holdings LLC, Cryoport Inc., MNX Global Logistics LLC., Movianto, Clinical Trial Logistics, Thermo Fisher Scientific, World Courier Management Inc., Cardinal Health Inc., Parexel International Corporation

Global Bio-Pharmaceutical Logistics Market Trends and Insights

Major companies operating in the bio-pharmaceutical logistics Market are focusing on leveraging advanced technologies such as IoT-enabled temperature-controlled packaging to enhance shipment monitoring, traceability and product integrity. IoT-enabled temperature control packaging integrates sensors and connectivity to continuously monitor conditions such as temperature and location during transit, enabling capabilities such as real-time environmental tracking, asset management and automated alerts for excursions. For instance, in April 2025, Cold Chain Technologies LLC, a US-based packaging company, launched the CCT Tower Elite, an IoT-enabled reusable universal 1600 L temperature-controlled pallet shipper designed to support global pharmaceutical and biotech shipments, featuring integrated data loggers for near real-time temperature monitoring, live tracking and asset management, and compatibility with both Euro and US pallets. The CCT Tower Elite improves cost efficiency, operational visibility and supply chain reliability for temperature-sensitive product distribution.

What Are Latest Mergers And Acquisitions In The Bio-Pharmaceutical Logistics Market?

In March 2025, DHL Group GmbH, a Germany based logistics and supply chain services company, acquired CRYOPDP Inc. from Cryoport Inc. for an undisclosed amount. With this acquisition, DHL aims to expand and strengthen its specialized pharmaceutical and healthcare logistics capabilities within its Life Sciences and Healthcare division, enhancing its service offerings for clinical trials, biopharma, and advanced therapies. CRYOPDP Inc. is a US based specialty healthcare courier that provides white glove logistics and courier services focused on clinical trials, biopharma, and cell & gene therapies across a global network.

Regional Outlook

North America was the largest region in the bio-pharmaceutical logistics market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

What Defines the Bio-Pharmaceutical Logistics Market?

The biopharmaceutical logistics market includes revenues earned by entities by providing road shipping and rail shipping biopharmaceutical logistics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bio-Pharmaceutical Logistics Market Report 2026?

The bio-pharmaceutical logistics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including Market Report 2026?global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bio-pharmaceutical logistics Market Report 2026? The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the Market Report 2026?